Keckley Report July 29, 2024
The Blame and Shame Game spikes in election cycles as candidates pit themselves against their opponents. Healthcare plays its own version: last week is indicative:
- Monday, the Federal Trade Commission announced expansion of its ongoing investigation into the business practices of Fresenius and Davita—the 2 dialysis providers that control 70% of the $180 billion dialysis market. This focus is on their use of non-compete contracts with physicians used by the companies to manage their clinical workforce. Background: In April, 2024, the FTC issued a rule outlawing non-compete agreements widely used in employment contracts with clinicians.
- Tuesday, the House Oversight Committee heard testimony from the CEOs of the Big 3 pharmacy benefits managers (CVS Caremark, Express Scripts and OptumRx) who...
Today's Sponsors
Today's Sponsor